Mylan Australia confirms there is NO CURRENT EPIPEN® SHORTAGE - 9 March 2020

A&AA has spoken with the TGA about EpiPen® and EpiPen®Jr being listed on the TGA website shortages list https://apps.tga.gov.au/Prod/msi/Search/Details/adrenaline-epinephrine

The TGA have confirmed that whilst there is currently sufficient supply of EpiPen® and EpiPen®Jr from Mylan Australia, a change in distribution and constraining of existing supply by Mylan Australia will help people across Australia access EpiPen®/s fairly to help avert an EpiPen® shortage.  

Mylan Australia has said there is no shortage of EpiPen®s in Australia at present. Download PDF of Mylan letter here and letter is shown below.

The only change that has occurred is that instead of pharmacies placing orders through wholesalers, they are now placing them through the Mylan EpiPen Customer Service hotline on 1800 931 625. This change to ordering EpiPen®s is occurring to help with current access of EpiPen®s. As there is an even higher than predicted demand (unlike any other previous demand) which has left some pharmacies struggling to access EpiPen®s from wholesalers, this Mylan controlled ordering system means access will be fair and equal to all Australians no matter where they live. EpiPen®s can still be purchased over the counter but the number of over the counter devices for pharmacies will be evenly shared across the country. There should not be any change to consumer EpiPen access at present. People should be able to access devices both on prescription and off prescription if they are reasonable.

Please share this Mylan notice with your pharmacist if you need to order EpiPen®/s because your device/s has/ have expired or will be expiring in March 2020.

EpiPen No Shortage letter from Mylan 9 March 2020

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William


© 2023 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 



ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.